Advent Life Sciences

Advent Life Sciences accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $2.1B. The median disclosed raise is $62M, and the largest is Nalu Medical at $396M, ahead of Beacon Therapeutics ($290M) and AGTC ($290M).

The names that recur most often on these co-invested cap tables are Advent Life Sciences (18 companies), Forbion (3 companies), OrbiMed (3 companies), Columbus Venture Partners (3 companies), Novo Holdings (2 companies), Syncona (2 companies). By latest disclosed round, the market skews Series B (6), Series A (6), Growth (2), Series D (1).

• Companies tracked: 18
• Disclosed funding total: $2.1B across 18 companies
• Median disclosed raise: $62M
• Largest raise: Nalu Medical — $396M
• Stage mix: Series B 6 · Series A 6 · Growth 2 · Series D 1
• Most recent dated round: 2025-09-16

Best funded Advent Life Sciences companies

1. Nalu Medical — $396M (latest: Growth)
2. Beacon Therapeutics — $290M (latest: Series B)
3. AGTC — $290M (latest: Series B)
4. Moximed — $184M (latest: Series D)
5. Selecta Biosciences — $151M (latest: Series E)
6. Proximie — $130M (latest: Series C)
7. F2G — $100M (latest: Growth)
8. AviadoBio — $97M (latest: Series A)
9. Zikani Therapeutics — $62M (latest: Series A)
10. MiroBio — $61M (latest: Series A)
11. Amphista Therapeutics — $61M (latest: Series B)
12. Axonics Modulation Technologies — $59M (latest: Series B)
13. Argá Medtech SA — $59M (latest: Series B)
14. Curve Therapeutics — $51M (latest: Series A)
15. Epitopea — $45M

Advent Life Sciences — related firms and companies (56)

• Nalu Medical
• Beacon Therapeutics
• AGTC
• Moximed
• Selecta Biosciences
• Proximie
• F2G
• AviadoBio
• Investors like Zetta Venture Partners
• Investors like General Atlantic
• Investors like Shasta Ventures
• Artax Biopharma
• Investors like Western Technology Investment
• Investors like Blockchain Capital
• Investors like Uncork Capital
• Investors like Capital One Ventures
• Advent Life Sciences portfolio companies 2026
• Investors like Digital Currency Group
• Zikani Therapeutics
• Investors like Sapphire Ventures
• Investors like Lightbank
• Investors like Advent Life Sciences
• Investors like Great Oaks Venture Capital
• MiroBio
• Investors like DCVC
• Investors like Recursive Ventures
• Investors like CRV
• Investors like DCM Ventures
• Amphista Therapeutics
• Investors like Venrock
• Investors like Salesforce Ventures
• Investors like Slow Ventures
• Investors like Storm Ventures
• Axonics Modulation Technologies
• Firms like GV
• Investors like Trinity Ventures
• Investors like 500 Global
• Investors like F-Prime
• Argá Medtech SA
• Investors like AME Cloud Ventures
• Investors like Altos Ventures
• Investors like Correlation Ventures
• Investors like Peak XV Partners
• Curve Therapeutics
• Investors like Lux Capital
• Investors like Coinbase
• Investors like Initialized Capital
• Investors like Primary Venture Partners
• Epitopea
• Investors like RRE Ventures
• Investors like GIC
• Investors like Bain Capital
• Investors like Alexandria Venture Investments
• NeRRe Therapeutics
• Investors like B Capital
• Investors like Thirdbase Capital

Advent Life Sciences profile · All research reports